image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

Spire Healthcare - Private hospitals group on track for double digit growth

March 2015

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • SPI
  • Price:
  • 302p
Private hospital groups have been a happy hunting ground for TMI with UAE-focused Al Noor, 965p, having gained 50% on our original tip in August ’13, while UK-based Spire Healthcare, which we recommended at 265p last October, reached a high of 389p before the recent pull-back. Spire, which operates 39 private hospitals, is benefiting partly from demographic factors with increased life expectancy leading to an ageing population, which in turn is causing associated growth in chronic diseases. But Spire is also benefiting from structural changes developing in the UK healthcare market as significant healthcare cost inflation is playing havoc with the NHS’ finances and analysts forecast a £30bn funding gap developing by 2020 ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X